• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct18
Evommune, Inc. released FY2025 Q2 earnings on October 17, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.0241
03:00
Evommune, Inc. released FY2024 Semi-Annual Earnings on October 17, 2025 (EST) with actual revenue of USD 7 M and EPS of USD -20.2189
03:00
Evommune, Inc. released FY2024 Q2 earnings on October 17, 2025 (EST) with actual revenue of USD 0 and EPS of USD -18.3529
03:00
Evommune, Inc. released FY2025 Semi-Annual Earnings on October 17 (EST), actual revenue USD 3 M, actual EPS USD -18.2868
03:00
Oct10
Evommune, Inc. released FY2024 Q4 earnings on October 9, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.4684
03:00
Evommune, Inc. released FY2023 Annual Earnings on October 9, 2025 (EST), Actual Revenue: USD 5M, Actual EPS: USD -3.1898
03:00

Schedules & Filings

Schedules
Filings
Nov6
IPO(EST)

Listing Price USD 16

Oct17
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -13.57 M, EPS -1.0241

Oct9
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -19.07 M, EPS -1.4684

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
26.900
+298.05%
+20.912
SMX
330.500
+134.40%
+189.500
WHLR
6.150
+89.82%
+2.890
GURE
8.780
+85.23%
+3.880
DBRG
14.470
+48.87%
+4.757
TDIC
0.4015
+42.98%
+0.124
SPHL
4.679
+40.52%
+1.349
TORO
5.630
+36.32%
+1.540
RIME
1.990
+35.37%
+0.520
LICN
3.930
+34.13%
+1.000
View More